5/20/2025CTTQ Initiates Phase 3 Trial of HER2-Targeting Bispecific ADC TQB2102

5/20/2025Innovent's XNW5004 Receives Breakthrough Therapy Designation

5/20/2025CDE Solicits Comments on the 94th Batch of Reference Formulations for ...

5/20/2025CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...

5/20/2025CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...

5/20/2025CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...

5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...

5/20/2025How Trump's Proposed Price Cuts Could Hurt China's Innovative Drugmake...

5/20/2025'China's Ozempic' may vie with Eli Lilly, Novo Nordisk for global weig...

5/16/2025SMEI: China's Pharmaceutical Industry Seeks Stability and Innovation A...

5/16/2025US Tariffs on Pharmaceuticals Could Hit Chinese Export Firms’ Profit ...

5/16/2025ArkBio Reports Positive Mid-Stage Results for Anti-Fibrotic Candidate ...

5/16/2025China Approves Haisco Pharma's Anrikefon (HSK21542) for Postoperative ...

5/16/2025CSPC and Cipla Forge Exclusive U.S. Licensing Deal for Irinotecan Lipo...

5/16/2025China Approves Xuanzhu Bio's Birociclib for HR+/HER2- Advanced Breast ...

5/16/2025NMPA Approves CANbridge's Velaglucerase Beta for Gaucher Disease

5/16/2025NMPA Orders Package Insert/Label Update for Ranitidine Injection Amid ...

5/16/2025US Push to Decouple from China May Spike Drug Costs, Experts Warn

5/16/2025Nuance Pharma Reports Positive Phase 3 Results for Ensifentrine in Chi...

5/16/2025Viva Biotech Unveils Proprietary AI Platform to Reshape Drug Discovery

5/16/2025WuXi Biologics Offloads German Plant to Terumo, Refocuses on Singapore...

5/15/2025Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...

5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...

5/15/2025Hengrui Aims to Raise $1.27B in Hong Kong IPO

5/14/2025NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M

5/14/2025BRL Medicine's Allogeneic CAR-T Therapy Shows Promising Results in Ref...

5/14/2025Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...

5/14/2025RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...

5/14/2025CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...

5/14/2025Beigene Submits New Indication Application for BCL2 Inhibitor Sonrotoc...

Page:5/770 Total number of articles:23089: [First][<<] [3] [4] [5] [6] [7] [>>] [End]